September 6, 2021
Sunovion Pharmaceuticals, a US subsidiary of Sumitomo Dainippon Pharma, said on September 2 that it has granted exclusive commercial rights in Europe for apomorphine sublingual film APL-130277 to Portuguese drug maker BIAL for the treatment of Parkinson’s disease. Under the...read more